Abstract 6957: Triple Immune Checkpoint Blockade Induces Immune-Mediated Cardiomyocyte Injury Through PCSK9 and NLRP3 Pathways: Translational Implications for Cardio-Oncology Surveillance
Background: Immune checkpoint inhibitors (ICIs) have transformed cancer care, yet immune-related adverse events involving the cardiovascular system, particularly myocarditis, remain among the most severe and life-threatening complications. While dual ICI regimens are known to increase cardiotoxic risk, the cardiovas...